ST宜化(000422.SZ):聯合化工和新疆天運的合成氨、尿素裝置已復產
格隆匯 2 月 7日丨ST宜化(000422.SZ)公佈,2020年12 月,因冬季天然氣供應受限,公司子公司內蒙古鄂爾多斯聯合化工有限公司(“聯合化工”)和新疆天運化工有限公司(“新疆天運”)的合成氨、尿素裝置停產(詳見巨潮資訊網2020 年12 月8日公司公吿2020-107號、2020 年12 月18日公司公吿2020-116號)。近日天然氣供應方已恢復供氣,聯合化工和新疆天運的合成氨、尿素裝置已復產。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.